Protein Marker Spots Huntington's Years Early
Protein Marker Spots Huntington's Years Early
Protein Marker Spots Huntington's Years Early
Key points
اہم نکات
मुख्य बातें
- A protein found in spinal fluid and blood can reveal nerve damage in people who carry the Huntington's disease gene years before any symptoms appear, a new study suggests.
- Researchers at the Institut de Recerca Sant Pau in Barcelona measured neurofilament light chain, or NfL, a protein released when nerve cells are injured, in 296 people from Spanish and international cohorts.
- Among people in the earliest stage of the disease, who had no symptoms and no visible brain shrinkage, 78 percent had raised NfL in spinal fluid in the Barcelona group and 59 percent in blood, while 53 percent had raised levels in spinal fluid in the international group.
- A protein found in spinal fluid and blood can reveal nerve damage in people who carry the Huntington's disease gene years before any symptoms appear, a new study suggests.
- Researchers at the Institut de Recerca Sant Pau in Barcelona measured neurofilament light chain, or NfL, a protein released when nerve cells are injured, in 296 people from Spanish and international cohorts.
- Among people in the earliest stage of the disease, who had no symptoms and no visible brain shrinkage, 78 percent had raised NfL in spinal fluid in the Barcelona group and 59 percent in blood, while 53 percent had raised levels in spinal fluid in the international group.
- A protein found in spinal fluid and blood can reveal nerve damage in people who carry the Huntington's disease gene years before any symptoms appear, a new study suggests.
- Researchers at the Institut de Recerca Sant Pau in Barcelona measured neurofilament light chain, or NfL, a protein released when nerve cells are injured, in 296 people from Spanish and international cohorts.
- Among people in the earliest stage of the disease, who had no symptoms and no visible brain shrinkage, 78 percent had raised NfL in spinal fluid in the Barcelona group and 59 percent in blood, while 53 percent had raised levels in spinal fluid in the international group.
A protein found in spinal fluid and blood can reveal nerve damage in people who carry the Huntington's disease gene years before any symptoms appear, a new study suggests. Researchers at the Institut de Recerca Sant Pau in Barcelona measured neurofilament light chain, or NfL, a protein released when nerve cells are injured, in 296 people from Spanish and international cohorts. Among people in the earliest stage of the disease, who had no symptoms and no visible brain shrinkage, 78 percent had raised NfL in spinal fluid in the Barcelona group and 59 percent in blood, while 53 percent had raised levels in spinal fluid in the international group. Those with raised levels were typically 10 to 13 years from expected symptoms, compared with 23 to 24 years for those with normal levels. Blood and spinal-fluid readings tracked each other closely, suggesting blood tests could be used in large trials. The protein behind the disease itself, mutant huntingtin, was also found at the earliest stage but was harder to measure accurately. The findings, published in Movement Disorders, still need validation before the test can guide treatment decisions, but the authors say it could help select trial volunteers and track gene therapies before symptoms begin.
A protein found in spinal fluid and blood can reveal nerve damage in people who carry the Huntington's disease gene years before any symptoms appear, a new study suggests. Researchers at the Institut de Recerca Sant Pau in Barcelona measured neurofilament light chain, or NfL, a protein released when nerve cells are injured, in 296 people from Spanish and international cohorts. Among people in the earliest stage of the disease, who had no symptoms and no visible brain shrinkage, 78 percent had raised NfL in spinal fluid in the Barcelona group and 59 percent in blood, while 53 percent had raised levels in spinal fluid in the international group. Those with raised levels were typically 10 to 13 years from expected symptoms, compared with 23 to 24 years for those with normal levels. Blood and spinal-fluid readings tracked each other closely, suggesting blood tests could be used in large trials. The protein behind the disease itself, mutant huntingtin, was also found at the earliest stage but was harder to measure accurately. The findings, published in Movement Disorders, still need validation before the test can guide treatment decisions, but the authors say it could help select trial volunteers and track gene therapies before symptoms begin.
A protein found in spinal fluid and blood can reveal nerve damage in people who carry the Huntington's disease gene years before any symptoms appear, a new study suggests. Researchers at the Institut de Recerca Sant Pau in Barcelona measured neurofilament light chain, or NfL, a protein released when nerve cells are injured, in 296 people from Spanish and international cohorts. Among people in the earliest stage of the disease, who had no symptoms and no visible brain shrinkage, 78 percent had raised NfL in spinal fluid in the Barcelona group and 59 percent in blood, while 53 percent had raised levels in spinal fluid in the international group. Those with raised levels were typically 10 to 13 years from expected symptoms, compared with 23 to 24 years for those with normal levels. Blood and spinal-fluid readings tracked each other closely, suggesting blood tests could be used in large trials. The protein behind the disease itself, mutant huntingtin, was also found at the earliest stage but was harder to measure accurately. The findings, published in Movement Disorders, still need validation before the test can guide treatment decisions, but the authors say it could help select trial volunteers and track gene therapies before symptoms begin.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।